A randomized phase II study of standard-doseversushigh-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results

Samer A. Srour; Shaoying Li; Uday R. Popat; Muzaffar H. Qazilbash; Sara Lozano-Cerrada; Farzeneh Maadani; Amin Alousi; Partow Kebriaei; Paolo Anderlini; Yago Nieto; Roy Jones; Elizabeth Shpall; Richard E. Champlin; Chitra Hosing

doi:10.1111/bjh.14731

A randomized phase II study of standard-doseversushigh-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results

British Journal of Haematology ◽

10.1111/bjh.14731 ◽

2017 ◽

Vol 178 (4) ◽

pp. 561-570 ◽

Cited By ~ 5

Author(s):

Samer A. Srour ◽

Shaoying Li ◽

Uday R. Popat ◽

Muzaffar H. Qazilbash ◽

Sara Lozano-Cerrada ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

B Cell ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase Ii ◽

Phase Ii Study ◽

Long Term Results ◽

Randomized Phase Ii

Download Full-text

Reassessment of risk factors and long‐term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma

Hematological Oncology ◽

10.1002/hon.2604 ◽

2019 ◽

Vol 37 (3) ◽

pp. 310-313

Author(s):

Giancarlo Fatobene ◽

Camila da Cruz Gouveia Linardi ◽

Frederico Moreira ◽

Gabriela Matos Falcão Targueta ◽

Fernanda Maria Santos ◽

...

Keyword(s):

Risk Factors ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Hodgkin Lymphoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Long Term Results ◽

Classical Hodgkin Lymphoma

Download Full-text

Long-term Results of Autologous Stem Cell Transplantation in the Treatment of Patients With Congestive Heart Failure

Transplantation Proceedings ◽

10.1016/j.transproceed.2011.01.115 ◽

2011 ◽

Vol 43 (3) ◽

pp. 931-934 ◽

Cited By ~ 5

Author(s):

E. Oguz ◽

F. Ayik ◽

P. Ozturk ◽

C. Engin ◽

S. Nalbantgil ◽

...

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Long Term Results

Download Full-text

Combination Of Ifn-α/GM-CSF as Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): Results of a Prospective Phase II Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2008.12.211 ◽

2009 ◽

Vol 15 (2) ◽

pp. 68

Author(s):

D. Salmasinia ◽

J.S. Moreb

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Maintenance Therapy ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase Ii ◽

Phase Ii Study ◽

Gm Csf ◽

Prospective Phase

Download Full-text

Autologous stem cell transplantation in therapy resistant chronic inflammatory demyelinating disease (CIDP) A phase II study. Call for patients

Clinical Neurophysiology ◽

10.1016/j.clinph.2006.06.735 ◽

2007 ◽

Vol 118 (2) ◽

pp. e4-e5

Author(s):

S. Renaud ◽

P. Fuhr ◽

J. Halter ◽

A. Gratwohl ◽

A.J. Steck

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase Ii ◽

Demyelinating Disease ◽

Phase Ii Study

Download Full-text

Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: Preliminary Results of an IFM Phase II Study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.6653 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 6653-6653 ◽

Cited By ~ 16

Author(s):

J.-L. Harousseau ◽

M. Attal ◽

V. Coiteux ◽

A.-M. Stoppa ◽

C. Hulin ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase Ii ◽

Phase Ii Study ◽

Induction Treatment ◽

Newly Diagnosed ◽

Preliminary Results

Download Full-text

A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.516 ◽

2015 ◽

Vol 21 (2) ◽

pp. S324 ◽

Cited By ~ 1

Author(s):

Sally Arai ◽

Joseph Pidala ◽

Iskra Pusic ◽

Xiaoyu Chai ◽

Samantha Jaglowski ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Hematopoietic Stem ◽

Randomized Phase Ii

Download Full-text

131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.12.008 ◽

2015 ◽

Vol 21 (4) ◽

pp. 673-681 ◽

Cited By ~ 43

Author(s):

Gregory A. Yanik ◽

Judith G. Villablanca ◽

John M. Maris ◽

Brian Weiss ◽

Susan Groshen ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase Ii ◽

Phase Ii Study ◽

Intensive Chemotherapy ◽

New Approaches

Download Full-text

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994–2009

Bone Marrow Transplantation ◽

10.1038/bmt.2016.249 ◽

2016 ◽

Vol 51 (12) ◽

pp. 1569-1572 ◽

Cited By ~ 8

Author(s):

S Rosengren ◽

U-H Mellqvist ◽

H Nahi ◽

K Forsberg ◽

S Lenhoff ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Long Term Results ◽

High Dose ◽

Al Amyloidosis ◽

High Dose Melphalan

Download Full-text

High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1702468 ◽

2000 ◽

Vol 26 (1) ◽

pp. 61-67 ◽

Cited By ~ 17

Author(s):

F Bertucci ◽

P Viens ◽

JR Delpero ◽

VJ Bardou ◽

C Faucher ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Ovarian Carcinoma ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Long Term Results ◽

High Dose ◽

Advanced Ovarian Carcinoma ◽

High Dose Melphalan

Download Full-text

The Addition of Meloxicam to G-CSF Is Associated with Good Mobilization Rates, Faster Engraftment and Reduced Toxicity and Hospital Stay after Autologous Stem Cell Transplantation–a Phase II Study

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2014.11.187 ◽

2015 ◽

Vol 21 (2) ◽

pp. S136-S137

Author(s):

Biju George ◽

Auro Viswabandya ◽

Ansu Anbu Alex ◽

Kavitha Lakshmi ◽

Aby Abraham ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Hospital Stay ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Phase Ii ◽

Phase Ii Study ◽

Reduced Toxicity

Download Full-text